Eko Analysis Software vs SignalHF
AI Verdict
Choose Eko Analysis Software if…
Choose Eko Analysis Software if your primary need is the early detection of common cardiovascular conditions like heart murmurs and atrial fibrillation during routine examinations or remote patient monitoring. This tool is ideal for clinicians across various specialties who require an FDA-cleared AI to augment their auscultation skills and capture digital heart sound and ECG data for immediate analysis and secure storage.
View Eko Analysis Software →Choose SignalHF if…
Choose SignalHF if you are a cardiologist managing patients with cardiac implantable electronic devices (CIEDs) and require an FDA-cleared AI to predict heart failure hospitalizations within 30 days. This solution is best suited for proactive risk stratification and enabling early intervention strategies by analyzing comprehensive CIED data to generate actionable alerts for your care team.
View SignalHF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Analysis Software | SignalHF |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Unknown | SaaS |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Analysis SoftwareEko Analysis Software (Tool A) integrates with digital stethoscopes and a mobile app, providing a direct, hands-on clinical experience for point-of-care diagnostics. Its features for recording, playback, and visualization are designed for immediate clinician interaction. SignalHF (Tool B) focuses more on backend data analysis and alert management for care teams, which is less about direct patient interaction and more about data workflow.
Clinical Value
TieBoth tools offer significant and FDA-cleared clinical value by addressing critical needs in cardiology. Tool A excels in early, point-of-care diagnosis of heart murmurs and AFib for a broader patient population. Tool B provides crucial predictive insights for preventing major events like heart failure hospitalizations in patients with cardiac implantable electronic devices.
Pricing & Value
Eko Analysis SoftwareEko Analysis Software (Tool A) offers a transparent freemium model with a clear subscription path for full AI-powered features, allowing users to experience basic functionalities before committing. SignalHF (Tool B) only states 'contact for pricing' with no specified details, which lacks transparency and makes it difficult to assess its value proposition upfront.
Enterprise Readiness
SignalHFSignalHF (Tool B) is designed with 'manufacturer-agnostic compatibility with various CIEDs' and offers a 'unified platform for centralizing cardiac implantable device data,' making it highly suitable for integration into complex, multi-vendor enterprise healthcare environments. While Tool A is cloud-based and compliant, Tool B's explicit focus on integrating diverse CIED data gives it an edge for large-scale enterprise deployment.
Innovation
TieBoth tools demonstrate significant innovation in their respective applications. Eko Analysis Software (Tool A) innovates by integrating FDA-cleared AI into a traditional diagnostic tool like the stethoscope for real-time detection. SignalHF (Tool B) innovates by leveraging complex, existing data streams from various cardiac implantable electronic devices to provide a predictive algorithm for preventing heart failure hospitalizations.
Support & Docs
Eko Analysis SoftwareEko Analysis Software (Tool A) provides a comprehensive online Help Center with user manuals, quick start guides, how-to videos, FAQs, and troubleshooting tips, along with dedicated support for both individual and enterprise customers. SignalHF (Tool B) mentions 'instructions for use' and brochures, but lacks a publicly visible, comprehensive help center or extensive training resources comparable to Tool A.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Analysis Software | SignalHF |
|---|---|---|
| Tool Name | Eko Analysis Software | SignalHF |
| Company | Eko Devices | Implicity |
| Primary AI Function | Assists clinicians in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation; detects normal sinus rhythm and calculates cardiac time intervals. | Predicts heart failure hospitalizations within 30 days by analyzing data from various cardiac implantable electronic devices. |
| Target Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology |
| Key Data Input | Integrates with Eko's digital stethoscopes and mobile app; wireless auscultation with Bluetooth-enabled devices; recordings of heart sounds and ECGs. | Data from various cardiac implantable electronic devices (CIEDs) including pacemakers, ICDs, CRTs; analyzes physiological data, demographics, lead measurements, episodes, and therapies. |
| Key Output/Alerts | FDA-cleared AI for heart murmur detection, FDA-cleared AI for atrial fibrillation (AFib) detection, detection of normal sinus rhythm, calculation of cardiac time intervals, visualization of phonocardiograms (PCG) and ECG tracings, secure cloud-based storage. | Prediction of heart failure hospitalizations within 30 days; automatic alerts for care teams based on risk scores; AI-driven alert management to filter and highlight relevant events. |
Videos
Demos, reviews, and walkthroughs featuring Eko Analysis Software and SignalHF.
Frequently Asked Questions
More Comparisons
More matchups featuring Eko Analysis Software or SignalHF
Backers
Who funded each tool's parent company.